SAFETY EVALUATION OF RITANSERIN - AN INVESTIGATIONAL SEROTONIN ANTAGONIST

被引：13

作者：

BARONE, JA

BIERMAN, RH

CORNISH, JW

HSUAN, A

DRAKE, ND

COLAIZZI, JL

机构：

[1] ROBERT WOOD JOHNSON UNIV HOSP,PISCATAWAY,NJ

[2] JANSSEN PHARMACEUT,PISCATAWAY,NJ

[3] RUTGERS STUDENT HLTH SERV,NEW BRUNSWICK,NJ

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1986年 / 20卷 / 10期

关键词：

D O I：

10.1177/106002808602001006

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：770 / 775

页数：6

共 16 条

[1]

ARRIAGA F, 1984, 1JTH P CINP C FLOR, P726

[2]

CEULEMANS DL, 1984, 14TH P CINP C, P727

[3] THE INFLUENCE OF RITANSERIN, A SEROTONIN ANTAGONIST, IN ANXIETY DISORDERS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY VERSUS LORAZEPAM [J].

CEULEMANS, DLS ;

HOPPENBROUWERS, MLJA ;

GELDERS, YG ;

REYNTJENS, AJM .

PHARMACOPSYCHIATRY, 1985, 18 (05) :303-305

[4] SCL-90 AND MMPI - STEP IN VALIDATION OF A NEW SELF-REPORT SCALE [J].

DEROGATIS, LR ;

RICKELS, K ;

ROCK, AF .

BRITISH JOURNAL OF PSYCHIATRY, 1976, 128 (MAR) :280-289

[5]

DEROGATIS LR, 1983, CLIN PSYCHOMETRIC RE, P2

[6]

DOUGLAS WW, 1985, GOODMAN GILMANS PHAR, P633

[7]

EVERITT BS, 1976, ANAL CONTINGENCY TAB

[8]

FEDERER WT, 1965, EXPT DESIGN

[9] CARDIOVASCULAR EFFECTS OF KETANSERIN, A NEW ANTISEROTONERGIC AGENT IN THE TREATMENT OF ARTERIAL-HYPERTENSION [J].

FERRARA, LA ;

FASANO, ML ;

SORO, S ;

RUBBA, P ;

IANNUZZI, A .

JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (03) :187-192

[10]

FREUND RJ, 1981, SAS LINEAR MODELS, P159

← 1 2 →